Hypertrophic Cardiomyopathy
A Guide to Evaluation, Treatment and Underwriting
Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a condition characterized by thickening of heart muscle not secondary to a known underlying cause, such as hypertension or valvular heart disease. HCM runs in families, and over one thousand different mutations on several different genes have been identified.
Guide Includes:
-
Overview
-
Family History
-
Underwriting Considerations
-
Case Studies
Important
For open access to all our tools and resources, become a TA-Partner when you Register Here. Already registered? Sign in Here and go to the TA-Partners’ Resource Center where you will find links to all available tools & resources.